Expensify, Inc.
NASDAQ:EXFYSoftware - Application
+$0.35 today
- Market cap
- $157.19M
- Beta
- 1.80
- P/E (TTM)
- -7.0
- EPS (TTM)
- -$0.22
Volume 0.63M
Average 0.79M
EXFY Total Current Liabilities
All obligations due within one year.
Expensify, Inc.NASDAQ: EXFY
Total Current Liabilities · Q1 FY2026 · quarter ended Mar 2026
Total current liabilities falls 4.1% from a year ago
Total current liabilities stood at $45.34M at the end of Q1 FY2026, down 4.1% from a year earlier and down 2.3% from the prior quarter. Over 3 fiscal years it compounded at -8.4% a year.
Context
- Total current liabilities amounted to 23.8% of total assets at the end of Q1 FY2026, down 1.2 pp from a year earlier.
- Total current liabilities increased in 2 of the last 3 fiscal years.
What to watch
Whether total current liabilities keeps falling in the next quarterly balance sheet after a -4.1% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 46.41M USD
- Year-over-year change
- +22.1%
- 4-year CAGR
- -3.5%
| Period | Period end | Total Current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 46.41M | +22.1% |
| FY2024 | 2024-12-31 | 38.01M | -44.0% |
| FY2023 | 2023-12-31 | 67.89M | +12.5% |
| FY2022 | 2022-12-31 | 60.36M | +12.7% |
| FY2021 | 2021-12-31 | 53.58M | — |
Total Current Liabilities vs competitors
How EXFY compares with its peers on the latest reported figures
- EXFY's Mar 2026 total current liabilities of $45.34M is the 5th highest of the 10 companies compared; the peer median is $26.96M.
- Its year-over-year change of -4.1% is the 7th highest of 10, against a peer median of +1.0%.
- Total current liabilities amounts to 23.8% of total assets for EXFY, versus a peer median of 26.8%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $7.2B | +114292.6% | +1.4% | 37.7% | |
TEADTeads Holding Co. | Mar 2026 | $409.12M | -13.4% | +17.3% | 34.0% |
| Mar 2026 | $117.83M | +1.0% | +21.7% | 26.8% | |
| Mar 2026 | $52.57M | -3.8% | +2.4% | 41.8% | |
| Mar 2026 | $45.34M | -4.1% | -8.4% | 23.8% | |
SVCOSilvaco Group, Inc. Common Stock | Mar 2026 | $26.96M | -42.3% | +18.9% | 24.2% |
| Mar 2026 | $22.61M | -17.4% | -11.8% | 31.0% | |
| Dec 2025 | $16.6M | +180.6% | +96.6% | 24.0% | |
| Mar 2026 | $9.96M | +197.4% | -13.4% | 9.4% | |
HITHealth In Tech, Inc. | Mar 2026 | $7.05M | +4.3% | -40.1% | 24.3% |
| Peer median (excluding EXFY) | $26.96M | +1.0% | +2.4% | 26.8% | |
Competitors are the stored peer set for EXFY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 98.4M | 103.79M | 47.51M | 48.77M | 63.08M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 21.15M | 18.92M | 16.83M | 13.13M | 13.11M |
| Inventory | 0 | 8.83M | 0 | 0 | 0 |
| Other Current Assets | 30.66M | 46.76M | 67.25M | 62.89M | 71.23M |
| Total Current Assets | 157.64M | 187.12M | 137.23M | 136.88M | 153.01M |
| Property, Plant & Equipment (Net) | 18.13M | 15.24M | 20.81M | 19.06M | 17.75M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 6.36M | 6.88M | 12.49M | 16.23M | 13.6M |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 370K | 344K | 457K | 499K | 494K |
| Other Non-current Assets | 710K | 664K | 5.79M | 1.01M | 1.15M |
| Total Non-current Assets | 25.57M | 23.13M | 39.55M | 36.8M | 32.98M |
| Total Assets | 183.21M | 210.24M | 176.78M | 173.68M | 185.99M |
| Account Payables | 3.75M | 1.06M | 1.43M | 196K | 289K |
| Short-term Debt | 15.55M | 15.55M | 22.66M | 0 | 0 |
| Tax Payables | 4.94M | 2.72M | 3.39M | 3.47M | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 24.58M | 42.76M | 43.18M | 29.86M | 29.79M |
| Total Current Liabilities | 53.58M | 60.36M | 67.89M | 38.01M | 46.41M |
| Long-term Debt | 52.07M | 51.43M | 0 | 0 | 5.06M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 153K | 1.2M | 1.68M | 1.69M | 1.78M |
| Total Non-current Liabilities | 53.02M | 52.64M | 8.15M | 7.43M | 6.84M |
| Total Liabilities | 106.6M | 113M | 76.04M | 45.44M | 53.24M |
| Common Stock | 6K | 7K | 8K | 9K | 9K |
| Retained Earnings | (65.91M) | (97.57M) | (140.77M) | (150.83M) | (172.22M) |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 76.62M | 97.24M | 100.74M | 128.24M | 132.75M |
| Total Debt | 69.97M | 67.79M | 29.55M | 6.47M | 5.74M |
| Net Debt | (28.43M) | (36M) | (17.96M) | (42.31M) | (57.34M) |
Expensify, Inc.
NASDAQ:EXFY
Intrinsic Alpha fair value
Locked
Current Price
$1.63
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.